Katherine Mellow, APRN
Family · Jonesboro, ARNPI 1629791009
Payments from drug & device makers
Across 92 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$274
- Lilly USA, LLC$240
- GSK$188
- AstraZeneca$180
- Novo Nordisk$118
- Otsuka America Pharmaceutical, Inc.$73
- plus $389 from 16 others
What the payments were for
- Food & beverage$1,462100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $274 |
| Lilly USA, LLC | 17 | $240 |
| GSK | 7 | $188 |
| AstraZeneca | 9 | $180 |
| Novo Nordisk | 8 | $118 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Biogen | 2 | $52 |
| Lundbeck LLC | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Exact Sciences | 2 | $32 |
| Bayer | 2 | $29 |
| Amgen | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 3 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| Organon | 1 | $11 |
| Corium, LLC | 1 | $10 |
How this compares
$1,462 in reported general payments places this provider in the 75th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $656 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 58 | $600 |
| Fluticasone Propionate | 51 | $568 |
| Cefdinir | 30 | $504 |
| Methylprednisolone | 55 | $347 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 24 | $260 |
| Azithromycin | 44 | $209 |
| Doxycycline Hyclate | 29 | $178 |
| Clindamycin Hcl | 20 | $160 |
| Ondansetron OdtOndansetron | 17 | $131 |
| Diclofenac Sodium | 11 | $130 |
| Prednisone | 30 | $42 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other family in Jonesboro
- Stefanie BrackinJonesboro$51K
- Jessica MatthewsJonesboro$19K
- Kimberly DanielsJonesboro$14K
- Kimberly RoddyJonesboro$12K
- Christopher JordanJonesboro$12K
- Amber ToombsJonesboro$12K
- Tracy ThompsonJonesboro$11K
- Ashley SheltonJonesboro$10K
- Steven VanderbiltJonesboro$10K
- Erika VanceJonesboro$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.